Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Large B-Cell, Diffuse 6Leukemia 5Nausea 4Lymphoma, Non-Hodgkin 4Central Nervous System Neoplasms 4Vomiting 3Sarcoma 3Neuroblastoma 3Spinal Cord Neoplasms 2Retinoblastoma 2Oligodendroglioma 2Lymphoma, Large-Cell, Anaplastic 2Sezary Syndrome 1Recurrence 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Mycosis Fungoides 1Multiple Myeloma 1Motor Activity 1Medulloblastoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Leukemia, Biphenotypic, Acute 1Immunoblastic Lymphadenopathy 1HIV Infections 1

Interventions

Magnetic Resonance Spectroscopy 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2gallium Ga 68 dotatate 1fluorodopa F 18 1Vincristine 1Radiotherapy 1Gelclair 1Etoposide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Optic Nerve Glioma × Vincristine × Clear all
NCT00276640 2018-04-20

SIOP-LGG-2004

Societe Internationale d'Oncologie Pediatrique

Phase NA Completed
3,417 enrolled
CNS

Astrocytoma, Oligodendroglioma, Spinal Cord Neoplasms, Central Nervous System Neoplasms, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡